Advanced Solid Tumors
Showing 1 - 25 of 451
Advanced Solid Tumors Trial in Beijing (WJB001)
Not yet recruiting
- Advanced Solid Tumors
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 15, 2023
Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)
Recruiting
- Advanced Solid Tumors
- GEC255 tablets
-
Chengdu, Sichuan, ChinaChina West Hospital
Mar 14, 2023
Advanced Solid Tumors Trial in Beijing (HX009)
Active, not recruiting
- Advanced Solid Tumors
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciense
Feb 7, 2023
Advanced Solid Tumors Trial in Beijing (HX301)
Active, not recruiting
- Advanced Solid Tumors
-
Beijing, Beijing, ChinaNational center/cancer hospital,chinese Academy of Medical Scien
Feb 7, 2023
Advanced Solid Tumors Trial in Huntersville, Cleveland (2X-121 and dovitinib)
Recruiting
- Advanced Solid Tumors
- 2X-121 and dovitinib
-
Huntersville, North Carolina
- +1 more
Feb 1, 2023
Advanced Solid Tumors Trial in Chuo-ku (MEDI5752)
Active, not recruiting
- Advanced Solid Tumors
- MEDI5752
-
Chuo-ku, JapanResearch Site
Jan 19, 2023
Advanced Solid Tumors Trial in Beijing (KH617)
Recruiting
- Advanced Solid Tumors
-
Beijing, Beijing, ChinaBeijing Titan Hospital,Capital Medical University
Jan 17, 2023
Advanced Solid Tumors Trial in Madrid ([14C]CC-90010, CC-90010)
Not yet recruiting
- Advanced Solid Tumors
-
Madrid, M, Spain
- +1 more
Dec 23, 2022
Advanced Solid Tumors Trial in Hangzhou (QL1604 injection)
Active, not recruiting
- Advanced Solid Tumors
- QL1604 injection
-
Hangzhou, Zhejiang, ChinaCancer Hospital of The University of Chinese Academy of Sciences
Dec 5, 2022
Advanced Solid Tumors, Metastatic Solid Tumors Trial in Lyon (NP137, anti-PD-1/PD-L1)
Recruiting
- Advanced Solid Tumors
- Metastatic Solid Tumors
-
Lyon, FranceCentre Léon Bérard
Nov 30, 2022
Advanced Solid Tumors Trial (ASKB589 Injection)
Not yet recruiting
- Advanced Solid Tumors
- ASKB589 Injection
- (no location specified)
Nov 21, 2022
Advanced Solid Tumors, HER2-positive Breast Cancer Trial in United States (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041
Recruiting
- Advanced Solid Tumors
- HER2-positive Breast Cancer
- ZN-A-1041 50mg BID
- +12 more
-
Tucson, Arizona
- +6 more
Nov 16, 2022
Advanced Solid Tumors Trial (BAT8008 for Injection)
Not yet recruiting
- Advanced Solid Tumors
- BAT8008 for Injection
- (no location specified)
Nov 9, 2022